New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareSLU-PP-332 vs Thymalin

SLU-PP-332 vs Thymalin

Side-by-side comparison of key properties, dosing, and research.

Recovery & RepairFat Loss & Metabolic
SLU-PP-332
Immune SupportAnti-Aging & Longevity
Thymalin
Summary
SLU-PP-332 is a small molecule exercise mimetic that activates estrogen-related receptors ERRalpha and ERRdelta (ERRa/d), transcription factors that drive oxidative metabolism programs. In animal studies it significantly enhanced endurance capacity and metabolic fitness without exercise, mimicking many of the cardiovascular and metabolic adaptations of aerobic training.
Thymalin is a polypeptide complex isolated from calf thymus glands (developed by the Russian Gerontology Institute), shown to restore immune function, extend lifespan, and reverse thymic involution. Clinical studies demonstrate improved immune parameters and up to 40% reduction in mortality in elderly patients.
Half-Life
Not established in humans; rodent pharmacokinetics suggest hours
Not well characterized as a complex extract; individual peptides have varying kinetics
Admin Route
Oral (research), Subcutaneous (research)
SubQ, IM
Research
Typical Dose
Not established for humans; rodent studies used ~100 mg/kg/day
10 mg IM or SC daily
Frequency
Once daily in rodent studies
Once daily
Key Benefits
  • Significant enhancement of aerobic endurance capacity
  • Increases mitochondrial density and oxidative metabolism in muscle
  • Promotes beneficial shift toward oxidative muscle fiber phenotype
  • Improves cardiac efficiency and cardiovascular fitness markers
  • Potential for obesity, metabolic syndrome, and heart failure treatment
  • Exercise mimetic for populations unable to exercise (disability, frailty, disease)
  • Restores thymic function and T-cell immunity
  • Extends healthy lifespan (documented in long-term studies)
  • Reduces infectious disease incidence in elderly
  • Normalizes immune parameters in immunodeficiency
  • Anti-tumor immune surveillance
  • Improves vaccine response in elderly
  • Reduces cardiovascular mortality (40% in landmark Russian study)
  • Normalizes neuroendocrine function
Side Effects
  • Limited human data; all studies are preclinical (rodent)
  • Unknown cardiovascular effects with long-term or high-dose use in humans
  • Potential hormonal interactions via ERR pathway (ERRs modulate estrogen-related signaling)
  • Off-target effects not fully characterized
  • Very well tolerated in decades of Russian clinical use
  • Mild injection site reactions
  • Rare: mild allergic reaction (natural extract)
  • Transient flu-like symptoms on initiation (immune activation)
Stacks With